Federated Hermes’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.85M Buy
16,903
+578
+4% +$276K 0.01% 674
2025
Q4
$9.51M Buy
16,325
+12,440
+320% +$6.35M 0.02% 630
2025
Q3
$1.78M Buy
+3,885
New +$1.45M ﹤0.01% 964
2025
Q2
Sell
-58,025
Closed -$19.2M 2138
2025
Q1
$19.2M Buy
+58,025
New +$19.1M 0.04% 411
2022
Q4
Sell
-240,000
Closed -$15.6M 2231
2022
Q3
$15.6M Hold
240,000
0.05% 436
2022
Q2
$17.2M Sell
240,000
-102,597
-30% -$7.54M 0.05% 427
2022
Q1
$33.6M Buy
+342,597
New +$28.9M 0.08% 319
2021
Q4
Sell
-3,303
Closed -$264K 2259
2021
Q3
$264K Sell
3,303
-2,599
-44% -$224K ﹤0.01% 1619
2021
Q2
$575K Buy
+5,902
New +$699K ﹤0.01% 1478
2018
Q4
Sell
-18
Closed -$4K 2261
2018
Q3
$4K Sell
18
-4,525
-100% -$1.14M ﹤0.01% 2086
2018
Q2
$1.27M Buy
4,543
+4,523
+22,615% +$794K ﹤0.01% 1205
2018
Q1
$2K Sell
20
-266
-93% -$32.8K ﹤0.01% 2061
2017
Q4
$26K Buy
286
+123
+75% +$7.03K ﹤0.01% 1733
2017
Q3
$7K Buy
+163
New +$3.05K ﹤0.01% 1910

Other funds holding MDGL